![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ya6037contents.gif)
Acta Cryst. (2001). E57, o652-o654 [ doi:10.1107/S1600536801010248 ]
Abstract: The title compound, C9H10ClN3O2S, was prepared for structural comparison with analogous products known as myorelaxants and inhibitors of insulin release. The 2H-tautomeric form is imposed by the presence of a methyl group in the 2-position. There are four independent molecules (A, B, C and D) in the asymmetric unit which have almost the same geometry. The C-N distances in the four thiadiazine rings [C-N single- and double-bond mean values of 1.405 (3) and 1.304 (3) Å, respectively] may serve as reference to characterize the 2H-tautomeric form in analogous structures. The NH group of the methylamino substituent of each molecule participates in an intermolecular hydrogen bond with a sulfoxide O atom acting as acceptor. These four independent hydrogen bonds give rise to two types of infinite chains, both stretching along the a axis and having molecular compositions of ...ABABAB... and ...CDCDCD...
Copyright © International Union of Crystallography
IUCr Webmaster